The patient, aged 69 years, had a 43-year history of type 1 diabetes and was scheduled to undergo a chest wall resection.
SGLT2 inhibitor remogliflozin etabonate lowered HbA1c levels in patients with type 2 diabetes.
Researchers found that more non-English speaking, older male patients from low-income areas had preventable amputations.
A reduction in weight and glycohemoglobin was seen in patients that completed a diabetes prevention course.
Multifactorial management did not significantly reduce frequency of microvascular complications in type 2 diabetes patients.
A depression screening tool is cost and time effective and has been shown to make a positive impact on the management of DM in the outpatient setting.
Initiating insulin therapy at lower levels of HbA1c may help patients attain glycemic control.
A simple strategy helps more patients with diabetes receive annual clinical foot exams, but can it be translated to other aspects of diabetes management?